Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Sigma-Aldrich adds 2,000 antibodies to its Prestige portfolio

Sigma-Aldrich Research Biotech : 20 August, 2008  (New Product)
Sigma-Aldrich has added more than 2,000 antibodies to its range of Prestige Antibodies.
The antibodies are developed by the Human Proteome Resource and are commercially available through an exclusive partnership with Sigma-Aldrich and Atlas Antibodies. As part of a keynote HUPO 2008 Conference lecture given by Mathias Uhlen, professor of microbiology, Royal Institute of Technology (KTH) in Stockholm, Sweden, the new antibodies were announced as the latest additions to the Human Protein Atlas portal.

Initially consisting of 1,800 antibodies, the portfolio has grown to over 3,800 antibodies directed against 3,600 genes. The goal of the project is to produce several thousand antibodies per year and at least one antibody to all 22,000 non-redundant human proteins by 2015. The latest batch of antibodies will be available in Europe immediately and is expected to be available September 1, 2008 in the USA and in other international markets.

'The expansion of the Human Protein Atlas dramatically advances Sigma-Aldrich's antibody offerings,' said Dr David Smoller, president of Sigma-Aldrich's Research Biotech Business Unit. 'By providing high quality, highly-validated antibodies, we are addressing one of the largest obstacles faced by the proteomics and cell biology research communities.'

Prestige Antibodies are validated for specificity and are designed to have low cross-reactivity to other human proteins. Each Prestige antibody is accompanied by 576 tissue immunohistochemistry (IHC) images and 118 cell and cell line immunocytochemistry (ICC) images.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo